Susquehanna International Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $268M | Buy |
1,920,300
+474,800
| +33% | +$66.5M | 0.03% | 418 |
|
|
2025
Q4 | $177M | Sell |
1,445,500
-295,400
| -17% | -$35.9M | 0.02% | 583 |
|
|
2025
Q3 | $193M | Sell |
1,740,900
-629,500
| -27% | -$71.6M | 0.02% | 550 |
|
|
2025
Q2 | $263M | Buy |
2,370,400
+595,000
| +34% | +$63.3M | 0.04% | 377 |
|
|
2025
Q1 | $199M | Sell |
1,775,400
-241,900
| -12% | -$25M | 0.03% | 393 |
|
|
2024
Q4 | $186M | Sell |
2,017,300
-66,600
| -3% | -$6M | 0.03% | 447 |
|
|
2024
Q3 | $175M | Sell |
2,083,900
-1,400
| -0.1% | -$107K | 0.03% | 441 |
|
|
2024
Q2 | $143M | Buy |
2,085,300
+674,100
| +48% | +$45M | 0.03% | 460 |
|
|
2024
Q1 | $103M | Buy |
1,411,200
+303,200
| +27% | +$23.3M | 0.02% | 648 |
|
|
2023
Q4 | $89.8M | Sell |
1,108,000
-114,800
| -9% | -$8.93M | 0.02% | 726 |
|
|
2023
Q3 | $91.6M | Sell |
1,222,800
-59,500
| -5% | -$4.58M | 0.02% | 660 |
|
|
2023
Q2 | $98.8M | Buy |
1,282,300
+185,500
| +17% | +$14.8M | 0.02% | 619 |
|
|
2023
Q1 | $91M | Sell |
1,096,800
-520,500
| -32% | -$43.1M | 0.02% | 631 |
|
|
2022
Q4 | $139M | Buy |
1,617,300
+303,300
| +23% | +$24M | 0.04% | 436 |
|
|
2022
Q3 | $81.1M | Buy |
1,314,000
+412,500
| +46% | +$26M | 0.02% | 572 |
|
|
2022
Q2 | $55.7M | Sell |
901,500
-1,929,500
| -68% | -$119M | 0.01% | 792 |
|
|
2022
Q1 | $168M | Sell |
2,831,000
-2,289,100
| -45% | -$146M | 0.03% | 456 |
|
|
2021
Q4 | $372M | Sell |
5,120,100
-1,055,300
| -17% | -$72.7M | 0.06% | 284 |
|
|
2021
Q3 | $431M | Buy |
6,175,400
+334,400
| +6% | +$23.5M | 0.06% | 281 |
|
|
2021
Q2 | $402M | Sell |
5,841,000
-1,170,000
| -17% | -$78.1M | 0.06% | 279 |
|
|
2021
Q1 | $453M | Sell |
7,011,000
-2,506,100
| -26% | -$162M | 0.07% | 227 |
|
|
2020
Q4 | $554M | Buy |
9,517,100
+357,200
| +4% | +$21.6M | 0.09% | 166 |
|
|
2020
Q3 | $579M | Buy |
9,159,900
+1,995,400
| +28% | +$138M | 0.11% | 125 |
|
|
2020
Q2 | $551M | Sell |
7,164,500
-1,282,800
| -15% | -$98.3M | 0.13% | 108 |
|
|
2020
Q1 | $632M | Buy |
8,447,300
+1,571,000
| +23% | +$109M | 0.2% | 74 |
|
|
2019
Q4 | $447M | Buy |
6,876,300
+1,822,000
| +36% | +$119M | 0.13% | 123 |
|
|
2019
Q3 | $320M | Buy |
5,054,300
+1,015,800
| +25% | +$66.4M | 0.11% | 153 |
|
|
2019
Q2 | $273M | Sell |
4,038,500
-512,300
| -11% | -$33.7M | 0.1% | 166 |
|
|
2019
Q1 | $296M | Sell |
4,550,800
-2,433,000
| -35% | -$162M | 0.12% | 131 |
|
|
2018
Q4 | $437M | Buy |
6,983,800
+1,042,000
| +18% | +$72.8M | 0.17% | 90 |
|
|
2018
Q3 | $459M | Sell |
5,941,800
-1,929,300
| -25% | -$146M | 0.15% | 88 |
|
|
2018
Q2 | $558M | Buy |
7,871,100
+957,100
| +14% | +$67.6M | 0.19% | 66 |
|
|
2018
Q1 | $521M | Sell |
6,914,000
-5,669,900
| -45% | -$451M | 0.19% | 71 |
|
|
2017
Q4 | $902M | Buy |
12,583,900
+2,044,200
| +19% | +$155M | 0.32% | 42 |
|
|
2017
Q3 | $854M | Sell |
10,539,700
-1,768,300
| -14% | -$135M | 0.33% | 45 |
|
|
2017
Q2 | $871M | Buy |
12,308,000
+514,500
| +4% | +$34.2M | 0.38% | 36 |
|
|
2017
Q1 | $801M | Buy |
11,793,500
+1,739,700
| +17% | +$122M | 0.41% | 30 |
|
|
2016
Q4 | $720M | Sell |
10,053,800
-1,731,900
| -15% | -$129M | 0.37% | 35 |
|
|
2016
Q3 | $932M | Buy |
11,785,700
+3,961,900
| +51% | +$322M | 0.45% | 29 |
|
|
2016
Q2 | $653M | Buy |
7,823,800
+391,600
| +5% | +$34.8M | 0.35% | 38 |
|
|
2016
Q1 | $683M | Sell |
7,432,200
-2,935,000
| -28% | -$265M | 0.36% | 39 |
|
|
2015
Q4 | $1.05B | Sell |
10,367,200
-2,083,800
| -17% | -$217M | 0.48% | 29 |
|
|
2015
Q3 | $1.22B | Buy |
12,451,000
+2,230,700
| +22% | +$248M | 0.53% | 21 |
|
|
2015
Q2 | $1.2B | Sell |
10,220,300
-2,821,200
| -22% | -$308M | 0.51% | 22 |
|
|
2015
Q1 | $1.28B | Sell |
13,041,500
-5,576,200
| -30% | -$566M | 0.58% | 18 |
|
|
2014
Q4 | $1.75B | Buy |
18,617,700
+4,525,200
| +32% | +$468M | 0.7% | 13 |
|
|
2014
Q3 | $1.5B | Buy |
14,092,500
+3,346,100
| +31% | +$328M | 0.58% | 19 |
|
|
2014
Q2 | $891M | Buy |
10,746,400
+2,043,000
| +23% | +$159M | 0.38% | 26 |
|
|
2014
Q1 | $617M | Buy |
8,703,400
+3,001,300
| +53% | +$235M | 0.29% | 42 |
|
|
2013
Q4 | $429M | Buy |
5,702,100
+1,404,900
| +33% | +$97.8M | 0.2% | 69 |
|
|
2013
Q3 | $270M | Sell |
4,297,200
-536,300
| -11% | -$32.1M | 0.14% | 93 |
|
|
2013
Q2 | $248M | Buy |
+4,833,500
| New | +$252M | 0.14% | 90 |
|
Other funds holding GILD
VCM
VPM
Susquehanna International Group's GILD Position: Q1 2026 in Review
Susquehanna International Group increased its Gilead Sciences (GILD) stake by 76% in Q1 2026, buying an estimated $62.5M and bringing the position to 1,032,658 shares worth $144M. The position accounts for 0.02% of the portfolio, ranked #642.
Susquehanna International Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $762M in Q4 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Susquehanna International Group held 1,032,658 shares of Gilead Sciences worth $144M as of Q1 2026.
- Susquehanna International Group bought 446,635 Gilead Sciences shares in Q1 2026, an estimated $62.5M.
- Gilead Sciences made up 0.02% of Susquehanna International Group's portfolio in Q1 2026, its #642 holding.
- Susquehanna International Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Susquehanna International Group's Gilead Sciences position peaked at $762M in Q4 2014.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.